Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

4.620

-0.030 (-0.65%)

At close: Apr 23, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sales of Pharmaceutical Products			1.79B	1.35B	1.17B	909.33M	851.38M
Sales of Pharmaceutical Products Growth			32.32%	15.62%	28.55%	6.81%	11.19%
Services Toll Manufacturing			134.01M	132.44M	77.49M	50.84M	42.58M
Services Toll Manufacturing Growth			1.18%	70.91%	52.42%	19.39%	7.02%
Total			1.92B	1.48B	1.25B	960.17M	893.97M
Total Growth			29.54%	19.06%	29.81%	7.41%	10.98%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Egypt			1.74B	1.38B	1.16B	910.23M	828.86M
Egypt Growth			26.47%	18.89%	27.28%	9.82%	11.26%
Export			180.24M	106.51M	87.87M	49.94M	65.10M
Export Growth			69.23%	21.21%	75.96%	-23.29%	7.58%
Total			1.92B	1.48B	1.25B	960.17M	893.97M
Total Growth			29.54%	19.06%	29.81%	7.41%	10.98%

Source: S&P Global Market Intelligence.